GLP-1 agonists can lead to cognitive benefits, reduced inflammation, and lower inflammation markers.

“beyond the weight loss you know we're seeing cognitive benefits we're seeing you know inflammation benefits a lot of people with autoimmune disease who their inflammation markers are coming down”

“So I think obviously that person's going to get even more benefit if they have atapost tissue to lose that's causing inflammation. But I think especially if we think about autoimmune disease >> where people's immune system, their inflammatory response is mistriggering, I think that there's benefit for the GLP1s in that population specifically that is giving them an added benefit to decrease inflammation in a really profound way.”